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Abstract
Tumors can escape immune recognition and destruc-
tion through the induction of apoptosis in lymphocytes.
Although renal cell carcinoma (RCC) is able to prevent
immune recognition, only a few genes (such as FasL)
that are relevant for RCC immune escape have been
identified so far. We have previously shown that some
apoptosis-inducing genes are overexpressed in RCC.
We hypothesized that these genes could be part of the
immune-escape strategy of these tumors. Here we
report that CD70, a cytokine overexpressed in RCC,
promotes lymphocyte apoptosis through interaction
with its receptor CD27 and with the intracellular
receptor-binding protein SIVA. Apoptosis increased
after cocultivating lymphocytes with the RCC cell lines
A498 and CAKI2. The addition of recombinant soluble
CD70 to both native lymphocytes and a T-cell cell line
resulted in increased lymphocyte apoptosis as well.
Furthermore, induced apoptosis could be partially
blocked with anti-CD27 and anti-CD70 antibodies. Our
results strongly indicate a role for CD70 and CD27 re-
ceptor in lymphocyte apoptosis within the tumor
environment. Apoptosis mediated by exposure to
the CD70 secreted by tumor cells may contribute to
the failure of RCC patients to develop an effective
lymphocyte-mediated antitumor response.
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Introduction
Despite the presence of lymphocytes in tumors, solid tumors
successfully escape immune recognition. Clearly, an ef-
fective immune response can fail to develop in vivo. This
has been further elucidated by studies showing that the
tumor microenvironment has a deleterious effect on tumor-
infiltrating lymphocytes (TILs) [1]. It has been suggested that
tumor cells produce proteins that can induce apoptosis to
prevent recognition by TILs. Even though renal cell carci-
noma (RCC) is considered to be immune-suppressive and
TILs have been reported, only a few possibly involved genes
have been identified so far [2]. In gene expression studies
of RCC, we have previously shown an upregulation of several
immune-regulatory molecules, including TNFRSF10B, CD70,
TNFR1, PDGFRB, and BAFF, that are capable of inducing
apoptosis [3]. In the present study, we focused on the potential
of the surfacemarkerCD70 to induce apoptosis in lymphocytes.
It is a member of the tumor necrosis factor ligand superfamily 7.
In a previous study, we have identified this gene to be spe-
cifically overexpressed in clear cell RCC [4]. The upregulation
of CD70 in RCC is particularly interesting because, in a pre-
vious study, we found hints on its possible involvement in
immune-regulatory processes in RCC [5], and there is evi-
dence for its immune-regulatory function in glioblastoma [6].
CD70 is the only known ligand for its receptor CD27, and both
belong to the tumor necrosis factor receptor superfamily 7. It
is known that receptor activation can lead to proliferation, as well
as to apoptosis [6,7]. Interestingly, apoptosis can only be induced
in the presence of the intracellular receptor-binding protein SIVA.
This protein substitutes for themissing death domainof theCD27
receptor and mediates caspase activation [8].
To test whether CD70 upregulation in RCC has lymphocyte
cytotoxic function, we performed coculture experiments using
RCC cell lines and native lymphocytes or a T-cell cell line. We
show that CD70 expressed by RCC cell lines, as well as
rmsCD70, can induce lymphocyte apoptosis through interaction
with its receptor CD27. This finding points to a so-far-unknown
mechanism for RCC to escape immune recognition.
Materials and Methods
Established Cell Lines and Tissue Culture Conditions
Three RCC cell lines A498, CAKI1, and CAKI2 were main-
tained in RPMI 1640 (A498; Invitrogen, Carlsbad, CA) or DMEM
(CAKI1 and CAKI2; Invitrogen) supplemented with 10% fetal
Abbreviations: RCC, renal cell carcinoma; TIL, tumor-infiltrating lymphocyte; qPCR,
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bovine serum (FBS; Serum Med; Biochrom AG, Berlin, Ger-
many). The T-cell line MOLT4 (American Type Culture Collec-
tion, Manassas, VA) was maintained in complete RPMI 1640
(Invitrogen) supplemented with 10% FBS. All cell lines were
cultured at 37jC and 5% CO2.
Lymphocyte Isolation
Lymphocytes were isolated from the peripheral blood of
healthy persons using a lymphocyte separation medium
(PAA Laboratories GmbH, Pasching, Austria). Stimulation of
lymphocytes was carried out by adding 12 mg/ml phyto-
hemagglutinin A (BiochromAG). Lymphocytes were cultivated
for 72 hours in complete RPMI 1640 (Invitrogen) supple-
mented with 10% FBS at 37jC and 5% CO2 before adding
50 ng/ml rmsCD70 (Alexsis Biochemicals, Carlsbad, CA) to
the cell culture.
Expression of CD70, CD27, and SIVA
We assessed CD70 and CD27 expression in cell lines
using real-time polymerase chain reaction (PCR). Using the
commercially available RNeasy Kit (Qiagen, Valencia, CA),
total RNA isolation was performed according to the manu-
facturer’s instructions. Using SuperScriptII reverse transcrip-
tase (Invitrogen), RNA (2 mg) was reverse-transcribed with
100 mM random hexamer primers according to the manufac-
turer’s protocol. Using a commercially available master mix
containing HotStartTaq DNA polymerase and SYBR Green I
deoxyribonucleoside triphosphates (QuantiTect SYBRGreen
PCR Kit; Qiagen), real-time reverse transcription (RT) PCR
was performed with a LightCycler (Roche Molecular Bio-
chemicals, Mannheim, Germany) in capillaries. The following
real-time PCR protocol was used for all genes: initial 95jC
denaturation phase of 15 minutes to activate the HotStart
enzyme, followed by 45 rounds of amplification and quantifi-
cation (15 seconds at 95jC; 10 seconds at 55jC; 30 seconds
at 72jC), each with a single fluorescence measurement.
The specificity of desired RT-PCR products was docu-
mented using gel electrophoresis and melting curve analysis
(LightCyler Software Version 3.5, 2001; Roche Molecular
Biochemicals). Primers were designed for the CD70 gene
(3V–5V: AATCACACAGGACCTCAGCAGGACC; 5V–3V:
AGCAGATGGCCAGCGTCACC). For the genes CD27,
SIVA, and ILRAP1 (reference gene), QuantiTect Primer
Assay (Qiagen) was used. Product-specific melting curves
showed only single peaks and no primer dimer peaks or
artifacts. The ‘‘Delta Delta CT method’’ was applied to com-
pare relative expression results in real-time PCR [9].
Immunohistochemistry (IHC)
Using DAKO Kit 5005 (DAKO, Glostrup, Denmark), IHC
was performed on an RCC cell monolayer in a 96-well plate
according to the manufacturer’s instruction. In short, the cell
monolayer was fixed in acetone and washed with Tris buffer/
Tween [0.1% wt/vol Tween (TBS-T)]. Slides were overlaid
with 0.1% avidin and 0.01% biotin. Biotin blocking was per-
formed using the biotin blocking system from DAKO. After
washing with TBS-T twice, protein blocking was carried
out using a blocking solution containing goat serum in TBS,
RPMI 1640, and sodium azide. Slides were washed and
incubated with TBS-T. The primary antibody–antigen re-
action was performed with antibody against CD70 (1:250 di-
lution; Ancell, Bayport, MN), CD27 (1:250 dilution; Ancell),
and SIVA (1:200 dilution; Abnova, Taipei City, Taiwan) over-
night at 4jC to 8jC. After washing with TBS-T, slides were
incubated with biotin-coupled secondary antibody (DAKO Kit
5005) according to the manufacturer’s instructions. Slides
were washed with TBS-T, and avidin–alkaline phosphatase
(DAKO Kit 5005) solution was added. After washing with
TBS-T, enzyme reaction was carried out by adding a sub-
strate solution (DAKO Kit 5005). Slides were washed with
water. Finally, cells were stained with Hemalaun solution.
Analysis of Lymphocyte Apoptosis
MOLT4 cells were resuspended at a concentration of 1 
106 cells/ml in PBS (Invitrogen) before being added to flasks
containing an RCC cell monolayer at a 1.5:1 tumor cell/
lymphocyte ratio. The cells were cocultivated in FBS-free
medium for 3 hours. Floating lymphocytes were removed
from RCC monolayers and assessed for apoptosis using
APO-One Homogeneous Caspase-3/7 Assay (Promega,
Madison, WI) according to the manufacturer’s directions.
Blocking experiments were performed by adding mouse
monoclonal anti-human CD70 or mouse monoclonal anti-
human CD27 antibodies (both from Ancell) when Tcells were
incubated with RCCmonolayers. Both were used at a dilution
of 5 mg/ml. The isotype control for CD70 antibody was purified
mouse immunoglobulin G1 (Ancell). RmsCD70 was added to
1  106 cells/ml MOLT4 cells and native lymphocytes at a
concentration of 50 ng/ml. The cells were cultivated in FBS-
free medium for 3 hours before the performance of APO-One
assay (Promega).
Results
RCC Cell Lines Express CD70 Ligand But Not
CD70 Receptor
To test whether RCC cell lines express the components
required for CD70-initiated apoptosis, CD70, SIVA, and
CD27 expression levels were analyzed using quantitative
PCR (qPCR) and IHC.
All RCC cell lines tested through qPCR expressed the
CD70 ligand, although only a negligible expressionwas found
in the CAKI1 cell line (Table 1). In contrast, the A498 cell line
Table 1. Expression Ratios of CD70 and SIVA in Cell Lines Used, as
Determined by qPCR.
Cell Line Relative Expression
CD70 SIVA
A498 351.52 0.23
CAKI1 0.16 NM
CAKI2 1.71 0.07
CD70 expression ratios in RCC cell lines were compared to those in normal
renal tissues. SIVA expression ratios in RCC cell lines were compared to
those in MOLT4 cells.
NM, not measured.
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showed a very prominent induction of CD70 compared to
normal renal tissues. Experiments were performed in dupli-
cate, and deviation within the standard error lies between
0.007% and 0.14%.
In comparison to MOLT4 cells, the RCC cell lines A498
and CAKI2 showed less expression of SIVA (Table 1). These
experiments were performed in duplicate, and the standard
error lay between 0.01% and 0.27%. Additionally, expression
of CD70, CD27, and SIVA in native lymphocytes was com-
pared to that of MOLT4 T cells by qPCR (Table 2). A higher
expression level for all three genes was found in native
lymphocytes (Table 2). These experiments were performed
in duplicate, and the standard error lay between 0.05%
and 0.23%.
Confirmation with IHC at the protein level showed a clear
signal for CD70 in the cell line A498. In both cell lines CAKI2
and CAKI1, signals could also be detected even though
staining was more heterogeneous than that of A498 cells
(Figure 1). In contrast, staining for CD27 resulted in only weak
signals in all three cell lines (Figure 1). For SIVA, a clear signal
could be detected in A498 cells, whereas CAKI1 and CAKI2
cells showed weaker signals (Figure 1).
RCC Cells Induce Apoptosis in MOLT-4 T Cells
The RCC cell lines CAKI1, CAKI2, and A498 were co-
cultured with MOLT-4 T cells for 3 hours. Apoptosis was
assessed in T cells with caspase 3/7 assay after separation
from adherent growing RCC cells. Two of these three RCC
cell lines (A498 and CAKI2) induced T-cell apoptosis, where-
as no effect was observed with CAKI1 (Figure 2). RCC-
induced apoptosis in MOLT-4 T cells was 1.31-fold for A498
(n = 6) and 1.38-fold for CAKI2 (n = 4; Figure 2).
To test whether this effect is mediated by CD70 expres-
sion and is transmitted through CD70/CD27 interaction,
blocking experiments in which anti-CD70 and anti-CD27
antibodies had been added were performed. MOLT4 T
cells cocultured with the CD70+ RCC cell lines A498 and
CAKI2 were completely protected from induced apoptosis
when anti-CD70 antibody (P = .019 for A498; P = .046
for CAKI2) or anti-CD27 antibody (P = .0014 for A498;
P = .16 for CAKI2; Figure 2) was added to the cell culture.
Mouse immunoglobulin G1 was used as negative control
and showed no inhibitory effect.
Recombinant Soluble CD70 Induces Apoptosis
in Lymphocyte Culture
The effect of recombinant soluble CD70 (rmsCD70) on
lymphocytes was assessed to elucidate if the protein is
Table 2. Expression Ratios of CD70, CD27, and SIVA in Native Lympho-
cytes Versus Permanent MOLT4 T Cells, as Determined by qPCR.
Gene Relative Expression
CD70 2.69
CD27 2149.70
SIVA 6.79
Figure 1. Immunostaining for CD70, CD27, and SIVA on adherent growing cell lines. (A.1) Cell line A498 stained against CD70 (original magnification, 200). (A.2)
Cell line A498 stained against CD27 (original magnification, 200). (A.3) Cell line A498 stained against SIVA (original magnification, 300). (B.1) Cell line CAKI1
stained against CD70 (original magnification, 200). (B.2) Cell line CAKI1 stained against CD27 (original magnification, 200). (B.3) Cell line CAKI1 stained
against SIVA (original magnification, 300). (C.1) Cell line CAKI2 stained against CD70 (original magnification, 200). (C.2) Cell line CAKI2 stained against CD27
(original magnification, 200). (C.3) Cell line CAKI1 stained against SIVA (original magnification, 300).
Immune Escape for Renal Cell Carcinoma Diegmann et al. 935
Neoplasia . Vol. 8, No. 11, 2006
responsible for induced apoptosis rates in lymphocytes. After
the addition of 50 ng/ml rmsCD70 to permanently growing
MOLT4Tcells, an average of 1.26-fold (n= 5) T-cell apoptosis
was observed. Native lymphocytes showed an average of
1.34-fold (n = 2) apoptosis (Figure 3).
In summary, experiments with rmsCD70 and antibodies of
anti-CD27 and anti-CD70 revealed that CD70 has a direct
effect on the apoptosis rate of lymphocytes. RmsCD70-
induced apoptosis in MOLT4 Tcells was completely blocked
in the presence of anti-CD27 antibody (P = .030) and in the
presence of anti-CD70 antibody (P = .032; Figure 3). The in-
duced apoptosis rate in native lymphocytes was completely
blocked after the addition of anti-CD27 antibody (P = .011)
and anti-CD70 antibody (P = .005; Figure 3). In addition, the
inhibitory effect of anti-CD70 antibody observed on native
lymphocytes overcompensated for induced apoptosis. No
inhibitory effect was observed after the addition of mouse
immunoglobulin G1.
Discussion
Impaired antitumor immune responses are often observed
in RCCpatients, andRCC is generally known to be capable of
impeding immune response. Nevertheless, only a few mech-
anisms for RCC immunosuppression have been identified.
It has been demonstrated that alterations in proliferation,
effector functioning, and intracellular signaling in lympho-
cytes are rendered [10,11]. These findings and those of
others suggest that tumors have developed strategies to
evade the immune system through induction of apoptosis in
T cells [10,12–14]. One confirmed way for RCC to induce
apoptosis in lymphocytes is through FasL expression [2].
Another potential immune-regulatory gene,CD70, amem-
ber of the tumor necrosis superfamily, has been identified in
earlier studies to be specifically overexpressed in clear cell
RCC [3,4]. Although some information about CD70 is avail-
able, the role of this gene in tumor development and behavior
remains unclear. CD70 is a surface protein and ligand for
Figure 2. Apoptosis ratios of T cells cocultured with RCC cell lines CAKI1 (left), CAKI2 (middle), and A498 (right). Caspase activity ratios are shown relative to
normal caspase activity in MOLT-4 cells in culture. Vertical stripes: no antibody added; white: anti-CD70 antibody added; gray: anti-CD27 antibody added; black:
isotype control added.
Figure 3. Effect of recombinant soluble CD70 and anti-CD70 and anti-CD27 antibodies on the apoptosis rate of MOLT4 cells (left) and native lymphocytes (right).
Rmscd70 was added at a concentration of 50 ng/ml. Vertical stripes: no antibody added; white: anti-CD70 antibody added; gray: anti-CD27 antibody added; black:
isotype control added.
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CD27; both are members of the tumor necrosis factor re-
ceptor family [15]. Tumor necrosis factor/tumor necrosis fac-
tor receptor–related proteins have central roles in adaptive
and antigen-directed immunity when they coordinate the
response of lymphocytes to pathogens [16]. Herein we show
that CD70 expressed by RCC cell lines is responsible for
apoptotic cell death in lymphocytes.
The two tumor cell lines A498 and CAKI2, which express
CD70, were found to be capable of increasing apoptosis in
lymphocytes to about 30%, whereas the non–CD70-
expressing tumor cell line CAKI1 had no measurable influ-
ence on the apoptosis rate of T lymphocytes. Furthermore,
the addition of recombinant solubleCD70 (rmsCD70) in phys-
iological concentrations to both a T-cell cell line and native
lymphocytes in culture increased the apoptosis rate signifi-
cantly to about 26% and 34%, respectively. The involvement
of CD70 was shown by blocking experiments with antibodies
against the CD70 ligand and the CD70 receptor. We also
observed that the blocking effect of anti-CD70 antibody on
native lymphocytes overcompensates for the apoptosis in-
duced by rmsCD70 (Figure 3). We speculate that this could
be a hint to a general mechanism in lymphocytes involving
CD70/CD27 interaction as a regulatory pathway. Neverthe-
less, these findings have to be studied in more detail.
Recent data for CD70 lead to the assumption that apop-
tosis is mediated, in part, through the CD70/CD27 pathway
involving the apoptotic protein SIVA [6,17]. We could show
the expression of CD27, as well as of SIVA, in permanent and
native lymphocytes, whereas no expression was found in
permanent RCC cell lines. In addition, gene expression
studies of clear cell RCC showed no expression of CD27 in
tumor tissues [3]. These findings point to a specific activation
of the CD70/CD27 pathway in TILs. However, it remains
unclear how apoptotic signal is transmitted. The experimental
design of this study suggests two possibleways: the induction
of apoptotic signal through direct lymphocyte–RCC cell
contact (Figure 4A) or the cleavage and release of CD70 to
the surrounding environment. No direct cell –cell contact
would be necessary (Figure 4B). However, this needs to be
investigated in more detail.
Interestingly, RCC can induce the expression of immuno-
suppressive mediators, such as prostaglandin E2, by periph-
eral blood mononuclear cells [18]. It has already been
speculated that this finding, in combination with CD70 ex-
pression, may skew immune response to a prominent hu-
moral response or, even worse, may complete immune
escape/successful immunosuppression [19]. Our findings
support this hypothesis.
The assumption that CD70 could play a role in an immune-
escape strategy for cancer has been already examined for
glioblastoma, and the authors conclude that CD70 expressed
by glioma cells evoked immune inhibition rather than immune
stimulation [17]. However, a different study carried out by
Aulwurm et al. [20] suggests that immune-stimulatory effects
of CD70 override CD70-mediated immune cell apoptosis in
rodent glioma models and confer long-lasting antiglioma
immunity in vivo. These differing findings suggest that the
effects carried out after the activation of the CD70/CD27
pathway are highly complex. Little is known so far about
possible interaction partners for CD70 and CD27 that may
conduct regulatory functions as well.
In conclusion, our study provides evidence that apoptosis
in lymphocytes, induced through the expression of CD70,
could be a mechanism used by RCC to prevent immune
response. We showed that soluble CD70, as well as CD70
expressed by RCC cell lines, leads to apoptosis in lympho-
cytes through the CD70/CD27 pathway. Thus, we identified
another molecule that enables RCC to successfully escape
immune recognition.
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